AGIOAgios Pharmaceuticals, Inc.
What is the market doing?
No clear lean: in an uptrend, but heavily shorted (+12% of shares).
In an uptrend, above its rising 50- and 200-day averages. Overbought (RSI 75). Price is +18% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover. Down 7.2% since the previous count, up from 11.3% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How AGIO is trading
Agios Pharmaceuticals, Inc. is −11% over the past year while the S&P 500 is +16%: 27 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +18%
vs 200-day average · a clear uptrend
- RSI (14)
- 75
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 19%
Below its 52-week high
Details›
- Last close2026-10-23
- $36.99
- 1 monthS&P 500 −0.94%
- +13%
- 1 yearS&P 500 +16%
- −11%
- 5 yearsS&P 500 +86%
- −17%
- vs 50-day average$33.40
- +11%
- 52-week high
- $45.49
- 52-week low
- $22.34
- Annualised volatility
- 67%
| Year | Return |
|---|---|
| 2026 (year to date) | +36% |
| 2025 | −17% |
| 2024 | +48% |
| 2023 | −21% |
| 2022 | −15% |
| 2021 | −24% |
| 2020 | −9.3% |
| 2019 | +3.6% |
| 2018 | −19% |
| 2017 | +37% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 9 of 10 | +7.4% |
| Feb | 10 | 8 of 10 | +7.7% |
| Mar | 10 | 5 of 10 | −2.1% |
| Apr | 10 | 5 of 10 | −3.5% |
| May | 10 | 6 of 10 | +3.8% |
| Jun | 10 | 8 of 10 | +8.5% |
| Jul | 11 | 5 of 11 | −0.45% |
| Aug | 11 | 4 of 11 | −3.1% |
| Sep | 11 | 5 of 11 | +2.0% |
| Oct | 11 | 4 of 11 | −1.9% |
| Nov | 10 | 7 of 10 | +5.9% |
| Dec | 10 | 2 of 10 | −11% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.